Patents by Inventor Ralf LANGEN

Ralf LANGEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUNTINGTIN-RELATED PEPTIDE AGENTS AND USES THEREOF
    Publication number: 20230322854
    Abstract: Presented herein are novel peptides and peptide agents for diagnosing, preventing or treating Huntingtin's Disease.
    Type: Application
    Filed: September 3, 2021
    Publication date: October 12, 2023
    Inventors: Richard W. ROBERTS, Ralf LANGEN, Jeannie CHEN, Jose Mario ISAS, Kaori NORIDOMI, Terry TAKAHASHI
  • ANNEXIN-BASED APOPTOSIS MARKERS
    Publication number: 20130302827
    Abstract: The present invention describes an annexin derivative and a method of using the annexin derivative as a biosensor for real-time visualization of phosphatidylserine exposure, apoptosis, live-cell imaging and monitoring of cell health.
    Type: Application
    Filed: July 29, 2013
    Publication date: November 14, 2013
    Inventor: Ralf Langen
  • Annexin-based apoptosis markers
    Patent number: 8541549
    Abstract: The present invention describes an annexin derivative and a method of using the annexin derivative as a biosensor for real-time visualization of phosphatidylserine exposure, apoptosis, live-cell imaging and monitoring of cell health.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: September 24, 2013
    Assignee: University of Southern California
    Inventor: Ralf Langen
  • Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders
    Publication number: 20110020237
    Abstract: Compositions of matter and methods for inhibiting drusen or drusen-like deposits and/or for treating diseases related to drusen or drusen-like deposits in human or animal subjects by administering to the subject a therapeutically effective amount of i) a conformational epitope of an aggregate that contributes to the formation or biosynthesis of drusen or drusen-like deposits and/or ii) an antibody that binds to a conformational epitope of an aggregate that contributes to the formation or biosynthesis of drusen or the drusen-like deposit.
    Type: Application
    Filed: January 17, 2006
    Publication date: January 27, 2011
    Inventors: Charles G. Glabe, Rakez Kayed, Ralf Langen, Jeannie Chen, Jose Mario Isas, Volker Luibl
  • ANNEXIN-BASED APOPTOSIS MARKERS
    Publication number: 20090246802
    Abstract: The present invention describes an annexin derivative and a method of using the annexin derivative as a biosensor for real-time visualization of phosphatidylserine exposure, apoptosis, live-cell imaging and monitoring of cell health.
    Type: Application
    Filed: April 1, 2009
    Publication date: October 1, 2009
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventor: Ralf LANGEN